| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
An inhibitor of PI3K, which can influence downstream targets, possibly affecting YBX2-associated pathways. | ||||||
MEK Inhibitor I | 297744-42-4 | sc-353669 | 1 mg | $222.00 | 1 | |
MEK pathways are involved in various cellular processes. May indirectly affect YBX2-related processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that can impact MAPK signaling, indirectly influencing YBX2′s function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can affect downstream pathways linked with YBX2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, influencing MAPK signaling that could affect YBX2 activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-kB inhibitor that can influence inflammatory signaling, potentially affecting YBX2. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT inhibitor that can impact downstream targets and possibly influence YBX2 activity. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $176.00 $235.00 $281.00 $339.00 | 9 | |
Another PI3K inhibitor which can potentially have an effect on signaling pathways involving YBX2. | ||||||